Abstract
Background: The effect of immediate total-body CT (iTBCT) on health economic aspects in patients with severe trauma is an underreported issue. This study determined the cost-effectiveness of iTBCT compared with conventional radiological imaging with selective CT (standard work-up (STWU)) during the initial trauma evaluation. Methods: In this multicentre RCT, adult patients with a high suspicion of severe injury were randomized in-hospital to iTBCT or STWU. Hospital healthcare costs were determined for the first 6 months after the injury. The probability of iTBCT being cost-effective was calculated for various levels of willingness-to-pay per extra patient alive. Results: A total of 928 Dutch patients with complete clinical follow-up were included. Mean costs of hospital care were e25 809 (95 per cent bias-corrected and accelerated (bca) c.i. e22 617 to 29 137) for the iTBCT group and 26 155 (23 050 to 29 344) for the STWU group, a difference per patient in favour of iTBCT of 346 (4987 to 4328) (P=0.876). Proportions of patients alive at 6 months were not different. The proportion of patients alive without serious morbidity was 61.6 per cent in the iTBCT group versus 66.7 per cent in the STWU group (difference-5.1 per cent; P=0.104). The probability of iTBCT being cost-effective in keeping patients alive remained below 0.56 for the whole group, but was higher in patients with multiple trauma (0.8-0.9) and in those with traumatic brain injury (more than 0.9). Conclusion: Economically, from a hospital healthcare provider perspective, iTBCT should be the diagnostic strategy of first choice in patients with multiple trauma or traumatic brain injury.
Original language | English |
---|---|
Pages (from-to) | 277-285 |
Number of pages | 9 |
Journal | British Journal of Surgery |
Volume | 108 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2021 |
Bibliographical note
AcknowledgementsThe authors thank the following institutions and persons: ZonMw, the Netherlands Organization for Health Research and Development, for providing an unrestricted grant for the REACT-2 trial (ZonMw grant number 171102023); G. P. Clerx, T. N. Tromp, B. Bos, E. Baard, B. Visser, C. Bathelt and S. Purschke, research nurses at the participating sites, for their efforts in including patients and data completion; J. C. J. Noordegraaf, R. Siemons, C. van Ooijen, H. C. R. Nanninga, H. Hollander, B. J. Ponit, P. van Moorsel and L. van Moorsel, for gathering data on healthcare volume; M. J. A. M. Russchen and M. R. Wirtz, research students, for their assistance in data completion.
Publisher Copyright: © 2021 John Wiley and Sons Ltd. All rights reserved.